Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tiloket 50mg capsules
1001010L0BNACAA
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket CR 100mg capsules
1001010L0BNABAI
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket CR 200mg capsules
1001010L0BNADAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Valket 200 Retard capsules
1001010L0BNAAAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.